CO4940506A1 - Derivados de la 9-oxima eritromicina - Google Patents
Derivados de la 9-oxima eritromicinaInfo
- Publication number
- CO4940506A1 CO4940506A1 CO98033538A CO98033538A CO4940506A1 CO 4940506 A1 CO4940506 A1 CO 4940506A1 CO 98033538 A CO98033538 A CO 98033538A CO 98033538 A CO98033538 A CO 98033538A CO 4940506 A1 CO4940506 A1 CO 4940506A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- integer
- optionally substituted
- formula xvi
- ring
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 2
- 229960003276 erythromycin Drugs 0.000 title 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 7
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Un compuesto de la fórmula 1 o una sal farmacéuticamenteaceptable del mismo, en la que X es -CR7 R8 -o-NR7 -; o X es junto con R2 forma N=CR4 R5 ; o X y R2 juntos forman un anillo heterocíclico de fórmula XVI:En la que dicho anillo de fórmula XVI, r y p son cada uno de ellos independientemente un número entero de 1 a 3, q es O ó 1 y X1 es -CH2 -, O, -C(O)-, -C(S)-, -CH=CH-, CH(OH)CH(OH)-, o -NH-; y donde las partes (CH2 )r y (CH2 )p de dicho anillo de fórmula XVI están opcionalmente sustituidas con 1 a 4 sustituyentes y el átomo de nitrógeno cuando X1 es -NH- está opcionalmente sustituido con 1 sustituyente, estando dichos sustituyentes opcionales independientemente seleccionados entre el grupo constituido por -C(O) o (alquilo C1 -C10 ), alcoxi C1 -C10 , alcanoílo C1 -C10 , halógeno, nitro, ciano, heterociclilo de 5-10 elementos, alquilo C1 -C10 , -NR7 R8 , arilo C6 -C10 , -S(O)n (alquilo C1 -C10 ) donde n es un número entero de 0 a 2, y -SO2 NR7 R8 ; R1 es H o alquilo C1 -C10 , donde 1 a 3 carbonos de dicho alquilo están opcionalmente remplazados por un hetero+atomo seleccionado entre O, S y N, estando dicho alquilo opcionalmente sustituido con 1 a 3 sustituyentes seleccionados independientemente entre el grupo constituido por -C(O) O (alquilo C1 -C10 ), alcoxi C1 -C10 , alcanoílo C1 -C10 , halógeno, nitro, ciano, heterociclilo de 5-10 elementos, alquilo C1 -C10 , -NR7 R8 , arilo C1 -C10 , -S(O)n (alquilo C1 -C10 ) donde n es un número entero de 0 a 2 , y -SO2 NR7 R8 ; R2 es (y) H; R4 , -C(=)R4 , -C(O)OR4 , o -(CR7 R8 )m R3 cuando X es -NR7 -, o (II) H, R4 , o -CR7 R8 -, donde para ambos (i) y (ii) m es un número entero de 0 a 6 y tanto R7 como R8 pueden variar en cada caso en que m sea mayor que 1;...
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4934997P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4940506A1 true CO4940506A1 (es) | 2000-07-24 |
Family
ID=21959341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98033538A CO4940506A1 (es) | 1997-06-11 | 1998-06-11 | Derivados de la 9-oxima eritromicina |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0988308A1 (es) |
| JP (1) | JP2000513026A (es) |
| KR (1) | KR20010013660A (es) |
| CN (1) | CN1259135A (es) |
| AP (1) | AP9801253A0 (es) |
| AR (1) | AR012244A1 (es) |
| AU (1) | AU7226798A (es) |
| BG (1) | BG103947A (es) |
| BR (1) | BR9810021A (es) |
| CA (1) | CA2293335A1 (es) |
| CO (1) | CO4940506A1 (es) |
| CZ (1) | CZ9904388A3 (es) |
| EA (1) | EA199901016A1 (es) |
| GT (1) | GT199800074A (es) |
| HN (1) | HN1998000073A (es) |
| HR (1) | HRP980316A2 (es) |
| HU (1) | HUP0002252A3 (es) |
| ID (1) | ID24529A (es) |
| IL (1) | IL132767A0 (es) |
| IS (1) | IS5251A (es) |
| MA (1) | MA26505A1 (es) |
| NO (1) | NO996108L (es) |
| OA (1) | OA11225A (es) |
| PA (1) | PA8451801A1 (es) |
| PE (1) | PE79899A1 (es) |
| PL (1) | PL337606A1 (es) |
| TN (1) | TNSN98083A1 (es) |
| TR (1) | TR199902995T2 (es) |
| TW (1) | TW448174B (es) |
| WO (1) | WO1998056800A1 (es) |
| ZA (1) | ZA985018B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000159A (es) * | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
| DE69926005T2 (de) * | 1998-09-22 | 2006-05-18 | Pfizer Products Inc., Groton | Carbamat- und carbazatketolidantibiotika |
| FR2786188B1 (fr) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments |
| US6258785B1 (en) | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
| EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
| US6284732B1 (en) * | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| ID30547A (id) * | 1999-04-16 | 2001-12-20 | Kosan Biosciences Inc | Zat anti-infeksi makrolida |
| CN1351608A (zh) | 1999-05-24 | 2002-05-29 | 辉瑞产品公司 | 13－甲基红霉素衍生物 |
| WO2000075156A1 (en) * | 1999-06-07 | 2000-12-14 | Abbott Laboratories | 6-o-carbamate ketolide derivatives |
| ID27331A (id) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | Pembuatan antibiotik-antibiotik ketolida karbamat |
| EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
| EP1439186A3 (en) * | 1999-12-29 | 2004-11-03 | Pfizer Products Inc. | Intermediates for novel antibacterial and prokinetic macrolides |
| US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| US6403776B1 (en) | 2000-07-05 | 2002-06-11 | Pfizer Inc. | Synthesis of carbamate ketolide antibiotics |
| WO2003090761A1 (en) * | 2002-04-25 | 2003-11-06 | Abbott Laboratories | 9-oxime macrolide antibacterials |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| CA2529817C (en) * | 2003-03-10 | 2013-02-12 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
| CN102816194A (zh) | 2004-02-27 | 2012-12-12 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| JP5698979B2 (ja) | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
| EP2365747B1 (en) | 2008-10-24 | 2018-04-11 | Cempra Pharmaceuticals, Inc. | Methods for treating gastrointestinal diseases |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| EP2475253B1 (en) | 2009-09-10 | 2016-10-26 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and mac diseases |
| CN102146085B (zh) * | 2010-02-09 | 2014-03-26 | 北京理工大学 | 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物 |
| NZ602544A (en) | 2010-03-22 | 2014-11-28 | Cempra Pharmaceuticals Inc | Crystalline forms of a macrolide, and uses therefor |
| SI2571506T1 (sl) | 2010-05-20 | 2017-12-29 | Cempra Pharmaceuticals, Inc. | Postopki za pripravo makrolidov in ketolidov ter njihovih intermediatov |
| KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
| MX2014011537A (es) | 2012-03-27 | 2015-02-10 | Cempra Pharmaceuticals Inc | Formulaciones parenterales para la administracion de antibioticos macrolidos. |
| RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
| AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
1998
- 1998-05-15 JP JP11501928A patent/JP2000513026A/ja active Pending
- 1998-05-15 CN CN98805848A patent/CN1259135A/zh active Pending
- 1998-05-15 ID IDW991570A patent/ID24529A/id unknown
- 1998-05-15 EA EA199901016A patent/EA199901016A1/ru unknown
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Application Discontinuation
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/cs unknown
- 1998-05-15 PL PL98337606A patent/PL337606A1/xx unknown
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/xx unknown
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/pt not_active IP Right Cessation
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 IL IL13276798A patent/IL132767A0/xx unknown
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/ko not_active Ceased
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/hu unknown
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/es unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/es unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/es unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/es not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/zh active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/es unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/xx unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/fr unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/fr unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/hr not_active Application Discontinuation
- 1998-06-11 CO CO98033538A patent/CO4940506A1/es unknown
-
1999
- 1999-11-16 IS IS5251A patent/IS5251A/is unknown
- 1999-12-03 BG BG103947A patent/BG103947A/xx unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010013660A (ko) | 2001-02-26 |
| NO996108D0 (no) | 1999-12-10 |
| BR9810021A (pt) | 2000-09-19 |
| PL337606A1 (en) | 2000-08-28 |
| CA2293335A1 (en) | 1998-12-17 |
| BG103947A (en) | 2000-07-31 |
| AR012244A1 (es) | 2000-09-27 |
| AU7226798A (en) | 1998-12-30 |
| EP0988308A1 (en) | 2000-03-29 |
| IL132767A0 (en) | 2001-03-19 |
| GT199800074A (es) | 1999-11-27 |
| HRP980316A2 (en) | 1999-04-30 |
| WO1998056800A1 (en) | 1998-12-17 |
| HUP0002252A3 (en) | 2002-01-28 |
| IS5251A (is) | 1999-11-16 |
| PA8451801A1 (es) | 2000-05-24 |
| NO996108L (no) | 2000-02-10 |
| MA26505A1 (fr) | 2004-12-20 |
| TW448174B (en) | 2001-08-01 |
| JP2000513026A (ja) | 2000-10-03 |
| PE79899A1 (es) | 1999-08-25 |
| CN1259135A (zh) | 2000-07-05 |
| EA199901016A1 (ru) | 2000-06-26 |
| TNSN98083A1 (fr) | 2005-03-15 |
| HUP0002252A2 (hu) | 2000-12-28 |
| ZA985018B (en) | 1999-12-10 |
| AP9801253A0 (en) | 1999-12-04 |
| ID24529A (id) | 2000-07-20 |
| OA11225A (en) | 2003-07-17 |
| TR199902995T2 (xx) | 2000-02-21 |
| CZ9904388A3 (cs) | 2002-10-16 |
| HN1998000073A (es) | 1999-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940506A1 (es) | Derivados de la 9-oxima eritromicina | |
| ECSP034611A (es) | Aminotiazoles y su uso como antagonistas del receptor de adenosina | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| MX9705590A (es) | Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen. | |
| NO20022317L (no) | Trifenylalkylen-derivater og deres anvendelse som selektive östrogen-reseptor-modulater | |
| HRP20000835B1 (hr) | Derivati izotiazola korisni kao antitumorski agensi | |
| ES2111237T3 (es) | Derivados de la bencenosulfonamida y procedimiento de preparacion. | |
| ES2132373T3 (es) | Benzocicloheptenos, benzoxepinas y benzotiepinas. | |
| AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
| ID21568A (id) | Penggunaan baru untuk turunan 1,3-propanadiol | |
| CO4650117A1 (es) | Derivados de bencilsulfuro y proceso para su produccion . | |
| PE20010750A1 (es) | Derivados de espiro [2h-1-benzopiran-2,4`-piperidina] | |
| PT1064281E (pt) | Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais | |
| AR015964A1 (es) | Compuestos de isoquinolina, su uso, procedimiento para tratar una afeccion, procedimiento de preparacion del compuesto, composicion farmaceutica que locontiene y compuesto util en dicho procedimiento | |
| MX9605366A (es) | Derivados de amidina biciclicos como inhibidores de la oxido nitrico sintetasa. | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
| CO5200762A1 (es) | Preparacion de piperidin-4-onas sustituidas | |
| DK1381370T3 (da) | N-Biphenylcarbonyl- og N-phenylpyridylcarbonyl-substituerede bi- og tricykliske azepiner og diazepiner som vasopressin-agonister | |
| AR036734A1 (es) | Derivados de 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxilico | |
| ATE168686T1 (de) | N,n'-disubstituierte amidderivate | |
| ES447751A1 (es) | Procedimiento para preparar derivados de imidazolilquinazo- lina. | |
| FI902775A0 (fi) | Aryloxi-, aryltio-, heteroaryloxi-, heteroaryltio-alkylenderivat av aminer. | |
| GB1103875A (en) | Dibenzocycloheptadiene derivatives and their preparation | |
| PE20040943A1 (es) | 2-AMINOIMIDAZOLES SUSTITUIDOS COMO INHIBIDORES DEL INTERCAMBIADOR Na/H SUBTIPO 3 (NHE 3) |